TransMedics Group, Inc. (TMDX) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
TMDX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TMDX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 59.9% | 17.9% | 31.4% |
| 2024 | 59.4% | 8.5% | 8.0% |
| 2023 | 63.8% | -11.9% | -10.4% |
| 2022 | 69.8% | -33.6% | -38.8% |
| 2021 | 69.9% | -130.3% | -146.1% |
Download Data
Export TMDX earnings history in CSV or JSON format
Free sign-in required to download data
TransMedics Group, Inc. (TMDX) Earnings Overview
As of May 8, 2026, TransMedics Group, Inc. (TMDX) reported trailing twelve-month net income of $172M, reflecting +382.2% year-over-year growth. The company earned $4.75 per diluted share over the past four quarters, with a net profit margin of 31.4%.
Looking at the long-term picture, TMDX's historical earnings data spans multiple years. The company achieved its highest annual net income of $190M in fiscal 2025, representing a new all-time high.
TransMedics Group, Inc. maintains industry-leading profitability with a gross margin of 59.9%, operating margin of 17.9%, and net margin of 31.4%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AVXL (-$40M net income), STVN ($139M net income, 11.8% margin), NVCR (-$173M net income, -20.8% margin), TMDX has comparable earnings metrics. Compare TMDX vs AVXL →
TMDX Earnings vs Peers
Earnings metrics vs comparable public companies
TMDX Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $190M | +436.6% | $109M | $4.87 | 31.4% | 17.9% |
| 2024 | $35M | +241.7% | $37M | $1.01 | 8.0% | 8.5% |
| 2023 | -$25M | +30.9% | -$29M | $-0.77 | -10.4% | -11.9% |
| 2022 | -$36M | +18.1% | -$31M | $-1.23 | -38.8% | -33.6% |
| 2021 | -$44M | -53.8% | -$39M | $-1.60 | -146.1% | -130.3% |
| 2020 | -$29M | +14.3% | -$26M | $-1.16 | -112.1% | -102.9% |
| 2019 | -$34M | -41.2% | -$30M | $-2.36 | -142.1% | -125.4% |
| 2018 | -$24M | -14.1% | -$20M | $-1.23 | -182.5% | -155.5% |
| 2017 | -$21M | +13.5% | -$20M | $-1.44 | -271.0% | -265.8% |
| 2016 | -$24M | - | -$23M | $-1.66 | -387.6% | -370.2% |
See TMDX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TMDX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TMDX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTMDX — Frequently Asked Questions
Quick answers to the most common questions about buying TMDX stock.
Is TMDX growing earnings?
TMDX EPS is $4.75, with earnings growth accelerating to +382.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $172M.
What are TMDX's profit margins?
TransMedics Group, Inc. net margin is +31.4%, with operating margin at +17.9%. Above-average margins indicate pricing power.
How consistent are TMDX's earnings?
TMDX earnings data spans 2016-2025. The accelerating earnings trend is +382.2% YoY. Historical data enables comparison across business cycles.